There are significant opportunities to improve the health of all people through understanding and addressing health disparities present in our communities, particularly in key therapeutic areas such as oncology, cardiovascular, and inflammation. Improving health equity requires addressing both barriers to medical care and social determinants of health.
Amgen is working to advance policies and practices in support of achieving health equity so that all people have an opportunity to maximize health outcomes.
RISE is an Amgen program dedicated to improving the diversity and representation of participants in the company's clinical trials.
Amgen’s Health Equity Challenge is identifying scalable solutions to address core challenges to improving patient outcomes.
